# Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes

> **NCT00373178** · PHASE4 · COMPLETED · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 100 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** rosiglitazone
- **DRUG:** metformin
- **DRUG:** Anti-diabetic medications

## Key facts

- **NCT ID:** NCT00373178
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-01
- **Final completion:** 2008-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2012-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00373178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00373178, "Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00373178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*